The opportunities and challenges in conducting clinical trials globally

Clinical Research and Regulatory Affairs

Volumn 29, Issue 1, 2012, Pages 9-14

  Bansal, Navneeta ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

challenges; Clinical trial; globally

Indexed keywords

GEFITINIB; HYDROXYCHLOROQUINE; METHOTREXATE; ROSUVASTATIN; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL (TOPIC); COST CONTROL; DRUG USE; ETHNIC DIFFERENCE; HEALTH CARE COST; HUMAN; INFORMED CONSENT; MEDICAL PRACTICE; MEDICAL RESEARCH; NOTE; PATIENT SELECTION; RHEUMATOID ARTHRITIS; TREND STUDY;

EID: 84859595333     PISSN: 10601333     EISSN: 15322521     Source Type: Journal    
DOI: 10.3109/10601333.2011.647034     Document Type: Note

References (33)

1. Smith WT. FDA requires foreign clinical studies be in accordance with good clinical practices to better protect human subjects. ABA Health Source 2008;5:1-3.
2. Glickman SW, McHutchison JG, Peterson ED, Cairns CB, Harrington RA, Califf RM, Schulman K. Ethical and scientific implications of the globalization of clinical research sounding board. NEJM 2009;360:816-823.
3. Thiers FA, Sinskey AJ, Berndt ER. Trends in the globalization of clinical trials. Nature Rev Drug Disc 2008;7:13-14.
4. Huang G, Xu Q, Zang L, Halloran LA, Zhong JQ. Conducting global clinical trials in asia. Monitor 2009;23:42-46.
5. Berndt ER, Cockburn IM, Thiers FA. The globalization of clinical trials: where are the trials going and why? Harvard: Harvard Pharmaceutical Policy Seminar; 2008.
6. Manthei J, Watkins L, Thoelke KR, Hass JB. Global clinical trials: potential pitfalls of offshore trails 2008. Available online at: http://www.baybio.org/files/AC08-T4S3-Global-Clinical-Trials.pdf, accessed 28 August 2011.
7. Available online at: http://hepatitiscnewdrugs.blogspot.com/2011/01/ reality-check-outsourcing-of-clinical.html, accessed 28 August 2011.
8. Pasquali S, Burstein DS, Benjamin DK, Smith PB, Li JS. Globalization of pediatric research: analysis of clinical trials completed for pediatric exclusivity. Pediatrics 2010;126:e687-e982.
9. Agres T. Foundation of Chinese pharma. Drug discovery & development 2006. Available online at: http://www.dddmag.com/foundations-for-chinese-pharma. aspx, accessed 28 August 2011.
10. Shrestha BM. Informed consent: what it is all about. Kathmandu Univ Med J 2005;3:205-207.
11. Virk KP. Global clinical trials: the challenge of language. Lang Connect 2008.
12. Rugloski C. Training considerations when conducting global trials. San Antonio, TX: Proceedings of the DIA Annual Meeting; 17 June 2003.
13. Mackintosh DR. Opportunities to improve informed consent. Appl Clin Trials 2003;12:42-48.
14. Stober M. Multinational clinical trials. Appl Clin Trials 2003: September 24-30.
15. Widler B. How can we bring more structure into the audit process and into audit reports. San Antonio, TX: Proceedings of DIA Annual Meeting; 19 June 2003.
16. Binkowitz B. An overview of issues surrounding multi-regional clinical trials. Harvard Schering-plough 17th annual workshop: Merck & Co.; 2009.
17. Bruno M, Sietsema W. Regulatory challenges of global pivotal clinical trials Affairs Prof Soc 2007;12:10-14.
18. Perez M. The eCTD advantage. Appl Clin Trials 2009. Available online at: http://appliedclinicaltrialsonline.findpharma.com/appliedclinicaltrials/article/ articleDetail.jsp?id=620544, accessed 30 December 2011.
19. US Code of Federal Regulations. Title 21. Food and Drugs. Chapter I. Food and Drug Administration, Department of Health and Human Services, part 312. Investigational New Drug Application. Washington, DC: US Code of Federal Regulations; 2006.
20. Code of Federal Regulations. Title 21. Food and Drugs, volume 5, Section 312.1 (a), revised 1 April 2003. Available online at: http://www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?cfrpart=312&showfr=1, accessed 30 December 2011.
21. Khan F. The human factor: globalizing ethical standards in drug trials through market exclusion. DePaul Law Rev 2008;57:877-888.
22. European medicines agency. ICH Topic E 5 (R1) ethnic factors in the acceptability of foreign clinical data. 1998 CPMP/ICH/289/95. Available online at: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/ 2009/09/WC500002842.pdf,accessed 28 August 2011.
23. Day M. European drug agency calls for more ethical trials in developing countries. Br Med J 2010;341.
24. Schipper I. Clinical trials in developing countries: how to protect people against unethical practices? Directorate general for external policies of the union. Euro Parliament 2009;406.974(45):5.
25. Sinha G. Japan works to shorten "drug lag," boost trials of new drugs. J Natl Cancer Inst 2010;102:148-151.
26. Bjornsson TD, Wagner JA, Donahue SR, Harper D, Karim A, Khouri MS, Murphy WR, Roman K, Schneck D, Sonnichsen DS, Stalker DJ, Wise SD, Dombey S, Loew C. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol 2003;43:943-967. (Pubitemid 37022739)
27. Zuma A, Kudoh S. High prevalence of drug-induced pneumonia in Japan. Japan Med Assoc 2007;50:405-411. (Pubitemid 351175749)
28. Sekine I, Yamamoto N, Nishio K, Saijo N. Emerging ethnic differences in lung cancer therapy. Br J Cancer 2008;99:1757-1762.
29. Uyama Y, Shibata T, Nagai N, Hanaoka H, Toyoshima S, Mori K. Successful bridging strategy based on ICH E5 guideline for drugs approved in Japan. Clin Pharmacol Therapeut 2005;78:102-113. (Pubitemid 41112277)
30. Ichimaru K, Toyoshima S, Uyama Y. Effective global drug development strategy for obtaining regulatory approval in Japan in the context of ethnicity-related drug response factors. Practice 2010;87:362-366.
31. Feczko J, Harrigan R, Azoulay s, Morrison B, Berelowitz M, Rothenberg M, Urbanski R. The Globalization of clinical trials. Pfizer; 2009. Available online at: http://www.pfizer.com/files/research/nejm-paper-globalization-of-trials. pdf, accessed 30 December 2011.
32. Thoma M. Clinical trials go global overseas locations offer huge benefits - but also pose complex challenges. Business Planning Technol Dev 2008. Available online at: http://www.mddionline.com/article/clinical-trials-go- global, accessed 30 December 2011.
33. Schilsky RL. Opportunities and challenges of global clinical trials, from the president. Am Soc Clin Oncol 2009;26:3725-3730.